Home › Funds › Lion Point Capital, LP › BNTC

Lion Point Capital, LP position in BNTC

BENITEC BIOPHARMA INC · Health Care

Lion Point Capital, LP reported holding 62,000 shares of BNTC (BENITEC BIOPHARMA INC) in its Q2 2026 13F filing — a position valued at US$830K, representing 3.97% of its reported portfolio and ranking #8 among its reported holdings. Lion Point Capital, LP has disclosed BNTC holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)62.00K sh
Reported value held$829.56K
Portfolio Weight3.97%
First reportedQ3 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Lion Point Capital, LP's BNTC position evolved

Lion Point Capital, LP first disclosed a stake in BNTC in Q3 2024 at 39,000 shares (US$358K). The position peaked in Q3 2025 at 62,000 shares, worth US$870K. Across 8 filings, Lion Point Capital, LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 6 time(s). The most recent filing (Q2 2026) shows 62,000 shares valued at US$830K. Notable position changes include a 59% increase in Q4 2024 (shares rose 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 39.00K $358.41K New
Q4 2024 62.00K $783.06K Add
Q1 2025 62.00K $806.62K Hold
Q2 2025 62.00K $725.40K Hold
Q3 2025 62.00K $869.86K Hold
Q4 2025 62.00K $835.14K Hold
Q1 2026 62.00K $660.30K Hold
Q2 2026 62.00K $829.56K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BNTC and 13F data

BNTC (BENITEC BIOPHARMA INC) is a Health Care company. 56 other funds we track also report a position in BNTC — the largest reported positions include MONTANOVA CAPITAL, LLC (US$154.5M), Nantahala Capital Management, LLC (US$19.9M), Simplify Asset Management Inc. (US$13.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BNTC

All BNTC fund holders →

FAQ

How long has Lion Point Capital, LP held BNTC?

Lion Point Capital, LP has disclosed BNTC holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

What is Lion Point Capital, LP's current position in BNTC?

As of Q2 2026, Lion Point Capital, LP holds 62.00K shares of BNTC (BENITEC BIOPHARMA INC), valued at $829.56K, representing 3.97% of its reported portfolio and ranking #8.

Has Lion Point Capital, LP been buying or selling BNTC?

In the latest 13F filing (Q2 2026), Lion Point Capital, LP held unchanged its position in BNTC. The position peaked in Q3 2025 at 62.00K shares.

Which other funds hold BNTC?

Other major institutional holders of BNTC include MONTANOVA CAPITAL, LLC, Nantahala Capital Management, LLC, Simplify Asset Management Inc., among 56 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.